Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
People with a BMI below 27 and no weight-related health problems
Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double-blind, placebo-controlled, 24-week trial (GetGoal-M-Asia)
GLP-1 medications slow gastric motility, which can affect bowel function
[22] Finally, individual susceptibility factors such as pre-existing migraine disorders, stress related to managing a chronic condition, or anxiety about new medication may amplify the likelihood of experiencing headaches during GLP-1 therapy
US$ 25.20
US$ 27.56
US$ 25.52
US$ 27.71
